ABOUT NOVOTECH HEALTH HOLDINGS
Novotech is a leading Asia-Pacific biotech specialist CRO and consists of two operating brands, “Novotech” and “PPC”. Novotech is a clinical CRO with labs, phase I facilities, and drug development consulting services.
It has accumulated experience in over 3,700 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. Novotech is positioned to serve biopharmaceutical clients conducting clinical trials in Asia and globally.
As of September 30, 2021, Novotech had over 2,000 FTEs working across our offices in 11 geographies in Asia-Pacific and the United States.